APA (7th ed.) Citation

Urtishak, K. A., Wang, L., Harvey, R., Atlas, S. R., Chen, I. L., Robinson, B. W., . . . Felix, C. A. (2010). Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL-ENL, and gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial. Blood, 116(21), 2757. https://doi.org/10.1182/blood.V116.21.2757.2757

Chicago Style (17th ed.) Citation

Urtishak, Karen A., et al. "Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across Molecular/Cytogenetic Subtypes, Especially MLL-ENL, and Gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial." Blood 116, no. 21 (2010): 2757. https://doi.org/10.1182/blood.V116.21.2757.2757.

MLA (9th ed.) Citation

Urtishak, Karen A., et al. "Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across Molecular/Cytogenetic Subtypes, Especially MLL-ENL, and Gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial." Blood, vol. 116, no. 21, 2010, p. 2757, https://doi.org/10.1182/blood.V116.21.2757.2757.